Michinori Ogura, MD, PhD

Director of Department of Hematology, Head of Department of Clinical Trial Management, Tokai Central Hospital, Kakamigahara, Gifu, Japan

Dr. Ogura received an MD from Nagoya University School of Medicine, where he later completed a PhD. He completed his internship and residency in Internal Medicine at Konan Showa General Hospital and then a clinical and research fellowship in Hematology at Nagoya University Hospital. From 1944 to 2005, he was Deputy Director of Department of Hematology and Chemotherapy, Aichi Cancer Center Hospital. From 2005 to 2014, he was Director of Department of Hematology and Oncology and Head of Cancer Chemotherapy Center, Nagoya Daini Red Cross Hospital. From 2014 to 2015, he was Director of Department of Hematology, Suzuka National Hospital. From 2015, he is Director of Department of Hematology and Head of Department of Clinical Trial Management Tokai Central Hospital. From 2014, he is a visiting Professor at Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.

Dr. Ogura’s research interests include therapeutics of malignant lymphoma and leukemia (chemotherapy, antibody therapy, stem cell transplantation), development of therapeutics and new anticancer agents for hematological tumors, clinical oncology and cell biology of hematological tumors. As well as being influential member of many national hematology/oncology societies, he is an advisory board member of the Ministry of Health, Labour and Welfare Japan at the Pharmaceutical Affairs and Food Sanitation Council, Pharmaceuticals and Medical Devices Agency and a past member of Oncology Drug Advisory Committee of the Ministry of Health and Welfare Japan, and has been widely published in international literature of more than 100 medical publications. He has been a core member of the Lymphoma Study Group of Japan Clinical Oncology Group for more than 20 years.